Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$295,840,259
-$194,095,230 QoQ
Shares Held
546,002
-33.9% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#12
of 871 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $295,840,259 | 546,002 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $489,935,489 | 826,226 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $624,507,835 | 1,281,699 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $413,541,441 | 986,478 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $365,842,811 | 1,273,161 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $280,047,263 | 908,448 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $344,175,658 | 975,444 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $346,787,477 | 967,734 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $229,199,909 | 719,510 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $194,562,501 | 846,955 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $121,328,045 | 551,767 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $107,646,930 | 476,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $112,715,170 | 510,601 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $83,587,023 | 373,223 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $72,305,902 | 260,009 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $61,576,145 | 294,088 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,199,299 | 353,078 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $67,528,309 | 376,391 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $86,871,938 | 402,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $83,357,619 | 451,607 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $90,921,040 | 506,778 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $104,922,951 | 627,267 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $94,746,710 | 624,196 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $95,248,050 | 943,050 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $112,756,512 | 931,872 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $82,910,437 | 874,306 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||